Coronary Stent
Polymer-free Amphilimus™ (Sirolimus + Fatty Acid) eluting coronary stent. The absence of the polymer minimizes the risk of inflammation/thrombosis, while the propriety formulation enhances drug absorption.
REQUEST A QUOTEPolymer-free Amphilimus™ (Sirolimus + Fatty Acid) eluting coronary stent. The absence of the polymer minimizes the risk of inflammation/thrombosis, while the propriety formulation enhances drug absorption.
Abluminal Reservoir Technology
Controlled and directed drug elution as a result of the Abluminal Reservoir Technology
Amphilimus™ Formulation
Optimal efficacy achieved through an homogeneous drug distribution and improved bioavailability due to the proprietary Amphilimus™ formulation, which is the combination of Sirolimus plus Fatty Acid
Bio Inducer Surface
Proven bio and haemo-compatibility enabled by the Bio Inducer Surface coating, which accelerates the rate of endothelization and reduces thrombogenicity
http://www.alvimedica.com/images/d/library/0cacd6cb-3594-4944-b166-fa18ee6aa438.pdf